MORGAN STANLEY DL-,01/ US6174464486 /
24.05.2024 12:30:16 | Изменение -0.67 | Объем сделки | Бид13:03:52 | Предложение13:03:52 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
90.94EUR | -0.73% | 0 Оборот: 0.00 |
91.05Величина цены спроса: 130 | 92.01Величина цены предложения: 130 | 148.64 млрдEUR | - | - |
GlobeNewswire
14:37
Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework
GlobeNewswire
14:36
QuidelOrtho (QDEL) Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO,...
GlobeNewswire
14:35
Clean Energy and Precious Metals Hybrid Virtual Investor Conference: Presentations Now Available for...
GlobeNewswire
14:30
Roadzen to Participate in Fireside Chat at the Maxim Group TMT Conference on June 4, 2024
GlobeNewswire
14:30
Golden Triangle Ventures Announces Letter of Intent to Acquire Shipping and Logistics Operation
GlobeNewswire
14:30
Safe & Green Holdings Receives Crucial International Code Council (ICC), Recertification for Use of ...
GlobeNewswire
14:15
Rail Vision Reflects on Positive Operational Highlights Since the Start of 2024: Scaling Up Commerci...
GlobeNewswire
14:15
Bryant University names Todd M. Alessandri, Ph.D. new Dean of College of Business
GlobeNewswire
14:01
Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and ...
GlobeNewswire
14:00
BranchOut Food Inc. Secures Third EnWave Dehydration Machine; Announces $40M Production Capacity wit...
GlobeNewswire
14:00
Weebit Nano and Efabless collaborate to enable easy, affordable prototyping of innovative SoC design...
GlobeNewswire
14:00
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common...
GlobeNewswire
14:00
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница